Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

GammaPod revolutionizes breast cancer treatment: Italy introduces high-dose stereotactic radiotherapy in a single session to Europe

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

TEMA-SINERGIE

More Like This

PR Newswire associated0

KUBTEC® Scientific redefines preclinical image-guided radiotherapy with The XCELL® TomoRadTM x-ray irradiator

PR Newswire associated0

New technology aiming to improve patients' outcomes in breast cancer

Together with Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024

The treatment room at Stanford Medicine Cancer Center, Palo Alto, California, housing the Marie® upright patient positioning platform by Leo Cancer Care (center foreground) integrated with the Mevion S250-FIT™ Proton Therapy System. The circular rotating platform enables a patient seated in the Marie® chair to rotate 360 degrees in relation to a fixed proton beam — replacing the large rotating gantries required by traditional proton therapy systems. This compact configuration, which requires approximately 1,700 square feet compared with over 29,000 square feet for conventional proton therapy facilities, was used on June 4, 2026 to complete the world's first compact upright proton therapy patient treatment. The Marie® system is powered by RayStation from RaySearch. Photo: Steve Fisch / Stanford Medicine

Marie® by Leo Cancer Care Makes History at Stanford Medicine — World First in Compact Upright Proton Therapy

BetaGlue Therapeutics Expands its Clinical Trial in Italy after obtaining from the Italian Ministry of Health Approval to conduct its clinical study in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)

PR Newswire associated0

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

PR Newswire associated0

New data indicates use of 3D specimen tomosynthesis can improve breast cancer surgical outcomes

Business Wire logo

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Selects MEVION S250-FIT™ for Southern Italy’s First Proton Therapy Center

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us